Learn about brain health and nootropics to boost brain function
Improved learning, memory highlights synergy of two ingredients.
NEW YORK (PRWEB) May 30, 2019
A Japanese university study showed in mice that suffered cognitive impairment and then consumed a combination of Cognizin® Citicoline and docosahexaenoic acid, better known as DHA.
Researchers at Tohoku University administered a variety of tests to determine how citicoline and DHA impact brain activity following cerebral ischemia. Not only was the ability to learn and recall information improved, the combination may help prevent further brain cell death following a stroke brain infarction.
“DHA is a well-known ingredient that fights free radicals and is an important part of healthy brain development. Clinical studies show Cognizin® provides vital nutrients that -supports brain function by -helping brain communication, maintain healthy neurons and protect them from free radicals,” said Danielle Citrolo, PharmD, Registered Pharmacist Scientific & Regulatory Affairs Director, Kyowa Hakko USA. “The study showed that combining the two helped prevent further loss of brain cells and improved cognitive functions often damaged following celebral ishcemia. Pairing Cognizin® and DHA bridges good with good or the combo looks like it could have potential synergy and further research would be interesting.”
Cognizin® is a branded form of citicoline, a naturally occurring nutrient produced by the brain. Citicoline is critical for healthy brain function and is proven to increase alertness, as well as boost energy. Numerous clinical studies of Cognizin® Citicoline reinforce the ingredient’s ability to help improve focus, concentration, memory, and overall brain health.
The full Tohoku study was published Feb. 20, 2019, in the Journal of Pharmacological Sciences. For more information, visit https://www.sciencedirect.com/science/article/pii/S1347861319300234.
About Cognizin
Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and patented form of Citicoline, a natural substance made naturally in the body and especially vital to brain health. Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and recall. Cognizin is manufactured through an innovative fermentation process to yield high quality and high purity. Cognizin is also highly stable, GRAS, pure and allergen-free. For more information on Cognizin, visit Cognizin.com.
About Kyowa Hakko USA
Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as Sustamine® L-Alanyl-L-Glutamine. For more information visit Kyowa-USA.com.
About Kyowa Hakko Europe and Kyowa Hakko Bio Italia
Kyowa Hakko Europe and Kyowa Hakko Bio Italia are the Central-North and South European sales office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. For more information, visit http://www.kyowa.eu.
About Kyowa Hakko Bio Singapore Pte Ltd and Kyowa Hakko Bio India
Kyowa Hakko Bio Singapore Pte Ltd and Kyowa Hakko Bio India are the SE Asia & Australasia and India sales offices for KYOWA HAKKO BIO CO. LTD., an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Setria® Glutathione, as well as Sustamine® L-Alanyl-L-Glutamine. For more information, visit http://www.kyowahakko-bio.co.jp/english/ or email singapore(at)kyowa-asia(dot)com or india(at)kyowa-asia(dot)com.
Cognizin® is a registered trademark of Kyowa Hakko Bio Co., Ltd.
These statements have not been evaluated by the Food and Drug Administration or the European Commission. This product is not intended to diagnose, treat, cure, or prevent any disease.
For the original version on PRWeb visit: https://www.prweb.com/releases/a_powerful_duo_study_shows_kyowa_hakko_s_cognizin_citicoline_and_the_omega_3_dha_support_brain_function/prweb16344173.htm
Click here to view full article